PROC

Clinical trials for PROC explained in plain language.

Never miss a new study

Get alerted when new PROC trials appear

Sign up with your email to follow new studies for PROC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

Can a Two-Drug combo outsmart resistant ovarian cancer?

Disease control Not yet recruiting

This phase 2 trial is testing whether combining two drugs—mirvetuximab soravtansine and suvemcitug—can help people with a type of ovarian cancer that has stopped responding to platinum-based chemotherapy. The study will enroll 20 adults with FRα-positive, platinum-resistant recur…

Matched conditions: PROC

Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

PROC

Get alerted when new PROC trials appear

Can a Two-Drug combo outsmart resistant ovarian cancer?